查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877507

2025年人工智慧（AI）赋能的远距患者静脉输液（IV）监测市场报告

Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场发展迅猛，预计将从2024年的13.9亿美元成长到2025年的16.9亿美元，复合年增长率（CAGR）达21.8%。过去几年的成长可归因于以下几个因素：需要长期输液的慢性病患者增多、输液中心从住院转向门诊、肿瘤和免疫学领域生物疗法的普及、疫情后远距医疗模式的推广，以及由于护理人员短缺而导致的远距监测需求增加。

人工智慧 (AI) 赋能的远端患者静脉输液 (IV) 监测市场预计将在未来几年快速成长，到 2029 年达到 36.7 亿美元，复合年增长率 (CAGR) 为 21.4%。预测期内的成长要素包括居家医疗项目的扩展和普及、癌症治疗和自体免疫疾病专用输液药物的持续增长、护理人员短缺和职业倦怠日益严重、与安全性和疗效挂钩的价值导向型医疗奖励，以及促进合理家庭输液的支付方政策。预测期内的关键趋势包括用于检测外渗和渗漏的电脑视觉技术、用于监测插管部位组织变化的频谱光学感测技术、用于设备端分析的边缘人工智慧感测器贴片、用于预测阻塞、在线连续空气和流量异常的分析模型，以及使用快速医疗互通性资源 (FHIR) 应用程式编程介面实现的电子健康记录互通性。

远端医疗服务的扩展预计将推动人工智慧 (AI) 增强型远距患者静脉输液 (IV) 监测市场的成长。远端医疗服务利用数位通讯技术提供远端医疗咨询、监测和治疗。新冠疫情期间推出的监管政策和报销政策提高了医疗服务提供者和患者的可及性和经济可行性。人工智慧增强型远距患者静脉输液监测透过实现静脉输液治疗的即时追踪、併发症的自动检测、为医疗服务提供者提供可操作的洞察以及与虚拟护理平台的集成，为远端医疗提供支持，从而确保及时干预、提高患者安全并高效管理居家和门诊护理。例如，根据美国非营利组织 FAIR Health Inc. 于 2023 年 4 月发布的一份报告，全国远端医疗使用率成长了 7.3%，其在医疗索赔中所占份额从 2022 年 12 月的 5.5% 上升至 2023 年 1 月的 5.9%。远端医疗服务的扩展正在推动人工智慧增强型远距患者静脉输液监测市场的成长。

穿戴式健康技术的广泛应用预计将推动市场成长。智慧型手錶和健身追踪器等穿戴式装置能够即时监测健康指标。日益增强的健康意识和对即时健康资讯的需求正在推动这些技术的应用。穿戴式健康技术透过持续收集生理数据，支持远端患者静脉输液监测，从而实现异常检测、优化静脉输液治疗以及及时、个人化的干预，无需持续的面对面监测。例如，根据英国下议院图书馆2025年4月发布的报告，在2023年至2024年间，英国国家健康与临床优化研究所（NIHR）和英国研究与创新署（UKRI）投资约1500万美元（1150万英镑）用于10个研究计划，旨在开发可穿戴设备，以帮助残疾体弱或长期生活能力。因此，穿戴式健康技术的广泛应用正在促进人工智慧增强型远端患者静脉输液监测市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧 (AI) 增强型远端患者静脉输液 (IV) 监测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：成长率分析
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场表现：规模和成长，2019-2024年
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场预测：规模和成长，2024-2029年，2034年预测
  • 全球人工智慧 (AI) 增强型远端患者静脉输液 (IV) 监测：潜在市场规模 (TAM)

第六章 市场细分

  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：按组件划分，实际结果和预测，2019-2024年、2024-2029年预测、2034年预测
  • 硬体
  • 软体
  • 服务
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：依部署模式、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 本地部署
  • 云端基础的
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：按应用、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 医院
  • 诊所
  • 居家医疗环境
  • 门诊手术中心
  • 其他用途
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：按最终用户划分，实际值和预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 医疗保健提供者
  • 患者
  • 其他最终用户
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：按硬体、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 病患监测设备
  • 感测器和输液泵
  • 通讯设备
  • 资料储存系统
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：按软体、类型、实际值和预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 预测分析软体
  • 临床决策支援软体
  • 远端监控软体
  • 资料管理软体
  • 全球人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：按服务、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 实施和整合服务
  • 维护和支援服务
  • 培训和教育服务
  • 远端监控服务

第七章 区域和国家分析

  • 全球人工智慧（AI）赋能的远距患者静脉输液（IV）监测市场：区域分析、预测与趋势，2019-2024年、2024-2029年预测、2034年预测
  • 全球人工智慧（AI）赋能的远距患者静脉输液（IV）监测市场：国家/地区、市场表现及预测，2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：竞争格局
  • 人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：公司概况
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Epic Systems Corporation
  • ICU Medical Inc.
  • InfuSystem Holdings Inc.
  • AlayaCare Inc.
  • Huma Therapeutics Ltd.
  • Health Recovery Solutions Inc.
  • Arcomed AG
  • VitalConnect Inc.
  • Cloud DX Inc.
  • Empatica Srl
  • AccuHealth Inc.
  • Serum Tracker Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：提供新机会的国家
  • 2029年人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：提供新机会的细分市场
  • 2029年人工智慧（AI）赋能的远端患者静脉输液（IV）监测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39092

Artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring is a system that employs AI algorithms to continuously track and analyze IV therapy data in real time. It can identify irregularities, predict potential complications, and optimize fluid or medication delivery based on patient-specific patterns. The technology combines sensors, data analytics, and automated alerts to enhance safety and efficiency in IV treatment management.

The primary components of AI-enhanced remote patient intravenous (IV) monitoring include hardware, software, and services. Hardware comprises physical equipment and devices that collect, process, and support system operations, such as infusion pumps and wearable patient monitors. These systems can be deployed on-premises or via cloud platforms. They are applied in various settings, including hospitals, clinics, homecare, ambulatory surgical centers, and others, and are used by diverse end-users such as healthcare providers and patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market statistics, including artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market share, artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry. This artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market size has grown rapidly in recent years. It will grow from $1.39 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases requiring long-term infusions, the shift from inpatient to outpatient infusion centers, growth in oncology and immunology biologic therapies, post-pandemic adoption of remote care models, and nurse staffing shortages creating a greater need for remote oversight.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 21.4%. The growth during the forecast period can be attributed to the expansion of hospital-at-home programs and coverage, continued growth of specialty infusion drugs for oncology and autoimmune diseases, ongoing nursing workforce shortages and burnout, value-based care incentives linked to safety and outcomes, and payer policies encouraging appropriate home-based infusions. Key trends in the forecast period include computer vision-based detection of extravasation and infiltration, multispectral optical sensing to monitor tissue changes at the cannula site, edge AI on sensor patches for on-device analytics, predictive analytics models for occlusions, air-in-line, and flow anomalies, and electronic health record interoperability using Fast Healthcare Interoperability Resources (FHIR) application programming interfaces.

The expansion of telehealth services is expected to drive the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market. Telehealth services utilize digital communication technologies to provide remote medical consultations, monitoring, and treatment. Regulatory changes and reimbursement policies introduced during the COVID-19 pandemic have increased accessibility and financial viability for both providers and patients. AI-enhanced remote patient IV monitoring supports telehealth by enabling real-time tracking of IV therapy, detecting complications automatically, providing actionable insights to healthcare providers, and integrating with virtual care platforms to ensure timely interventions, improved patient safety, and efficient management of home-based and outpatient treatments. For example, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported that national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. The expansion of telehealth services is therefore driving growth in the AI-enhanced remote patient IV monitoring market.

The proliferation of wearable health technologies is expected to propel market growth. Wearable devices such as smartwatches and fitness trackers monitor health metrics in real time. Increasing health awareness and the demand for real-time health insights are driving the adoption of these technologies. Wearable health technologies support remote patient IV monitoring by continuously collecting physiological data, enabling the detection of anomalies, optimization of IV treatments, and timely, personalized interventions without constant in-person supervision. For instance, in April 2025, the UK Parliament's House of Commons Library reported that between 2023 and 2024, the NIHR and UKRI invested approximately USD 15 million (£11.5 million) in 10 research projects developing wearable technologies to support independence for people living with frailty or long-term physical disabilities. The proliferation of wearable health technologies is thus contributing to the growth of the AI-enhanced remote patient IV monitoring market.

Increasing healthcare expenditure is expected to support the growth of the AI-enhanced remote patient IV monitoring market. Rising financial resources in healthcare reflect growing demand for advanced medical technologies and services aimed at improving patient outcomes, enhancing treatment efficiency, and supporting AI-enabled remote monitoring. Higher healthcare expenditure facilitates investment in advanced technologies, digital infrastructure, and staff training to ensure more efficient and accurate patient care. For example, in June 2025, the Centers for Medicare & Medicaid Services reported that in 2023, national health expenditures increased by 7.5% to reach $4.9 trillion, averaging $14,570 per person and representing 17.6% of GDP. Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of total national health expenditures. Increasing healthcare expenditure is therefore driving the growth of the AI-enhanced remote patient IV monitoring market.

Major players in the artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market consists of revenues earned by entities by providing services such as continuous IV flow monitoring, AI-powered predictive analytics, remote patient monitoring, automated alerts and notifications, data management and reporting, telehealth integration, device management and support, and medication management support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market also includes sales of flow meters, pressure transducers, wireless control interfaces for infusion pumps, cloud-integrated drug infusion systems, and AI-enhanced remote monitoring platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Hardware; Software; Services
  • 2) By Deployment Mode: On-Premises; Cloud-Based
  • 3) By Application: Hospitals; Clinics; Homecare Settings; Ambulatory Surgical Centers; Other Applications
  • 4) By End-User: Healthcare Providers; Patients
  • Subsegments:
  • 1) By Hardware: Patient Monitoring Devices; Sensors And Infusion Pumps; Communication Devices; Data Storage Systems
  • 2) By Software: Predictive Analytics Software; Clinical Decision Support Software; Remote Monitoring Software; Data Management Software
  • 3) By Services: Implementation And Integration Services; Maintenance And Support Services; Training And Education Services; Remote Monitoring Services
  • Companies Mentioned: Medtronic plc; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Epic Systems Corporation; ICU Medical Inc.; InfuSystem Holdings Inc.; AlayaCare Inc.; Huma Therapeutics Ltd.; Health Recovery Solutions Inc.; Arcomed AG; VitalConnect Inc.; Cloud DX Inc.; Empatica S.r.l.; AccuHealth Inc.; Serum Tracker Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Characteristics

3. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Trends And Strategies

4. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Segmentation

  • 6.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hardware
  • Software
  • Services
  • 6.2. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Other Applications
  • 6.4. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Healthcare Providers
  • Patients
  • Other End-Users
  • 6.5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Monitoring Devices
  • Sensors And Infusion Pumps
  • Communication Devices
  • Data Storage Systems
  • 6.6. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics Software
  • Clinical Decision Support Software
  • Remote Monitoring Software
  • Data Management Software
  • 6.7. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implementation And Integration Services
  • Maintenance And Support Services
  • Training And Education Services
  • Remote Monitoring Services

7. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 9.1. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 9.2. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 10.1. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 11.1. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 11.2. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 12.1. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 13.1. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 14.1. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 14.2. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 15.1. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 16.1. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 17.1. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 18.1. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 19.1. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 20.1. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 21.1. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 22.1. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 23.1. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 23.2. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 24.1. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 24.2. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 25.1. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 25.2. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 26.1. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 26.2. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 27.1. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 28.1. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 28.2. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 29.1. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 29.2. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Nipro Corporation
  • 31.4. Epic Systems Corporation
  • 31.5. ICU Medical Inc.
  • 31.6. InfuSystem Holdings Inc.
  • 31.7. AlayaCare Inc.
  • 31.8. Huma Therapeutics Ltd.
  • 31.9. Health Recovery Solutions Inc.
  • 31.10. Arcomed AG
  • 31.11. VitalConnect Inc.
  • 31.12. Cloud DX Inc.
  • 31.13. Empatica S.r.l.
  • 31.14. AccuHealth Inc.
  • 31.15. Serum Tracker Inc.

32. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

34. Recent Developments In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

35. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer